Background: We estimated the burden of cancer using mortality and years of life lost according to life tables in a cohort study in Japan. Methods: A cohort of 13 270 subjects established in the late 1980s in Japan was followed annually for the vital status of all subjects until 2003. For subjects who died, the underlying cause of death was ascertained from the death certificate. Crude mortality rate from cancer per 100 000 person-years was calculated, and years of life lost (YLL) as well as the average years of life lost (AYLL) were computed using the 1995 life tables in Japan. Results: During the follow-up period, we recorded a total 839 cancer deaths (517 men and 322 women), representing 35.5% of deaths from all causes. Overall crude cancer mortality was 654.9 per 100 000 person-years in men and 312.6 in women. Total YLL due to cancer was 7035.3 years in men and 5627.0 years in women. Overall AYLL due to all cancers was 13.6 years less than life expectancy in men and 17.5 years in women. Conclusion: These results showed that cancer was the leading cause of death in this cohort; with stomach, liver and lung cancer the three most frequent cancers in both sexes. YLL and AYLL reflect the cost of dying from cancer in terms of years of life expectancy lost. The different mortality statistics used here may be useful in public health considerations of cancer burden.
Introduction
O ver recent decades, the Japanese have benefited from increasing life expectancy. This increase has also contributed to a rapid increase in the aged population. 1 With regard to disease burden in Japan, cancer overtook stroke in the early 1980s and is now the leading cause of death, as well as one of the main obstacles to continued improvement in life expectancy. Since cancer tends to strike at older ages, the absolute cancer burden in Japan is expected to worsen in line with the aging of the population.
The two outcomes most relevant to quantifying the burden of cancer are incidence and mortality. Incidence rates provide the clearest measure of the burden of carcinogenic exposures while mortality rates measure the risk of dying from a specific cancer or from all cancers. The target for improvement in cancer control is nevertheless a decrease in mortality, and the prevention of deaths occurring at an earlier age would contribute to reduce mortality. A more recently introduced mortality statistic that complements mortality is 'years of life lost' (YLL), [2] [3] [4] namely the number of years which would be saved in the absence of the disease. Given that analysis of death rates has traditionally played an important role in quantifying mortality statistics, high mortality may also be linked to an increase in premature deaths, although mortality does not directly reflect the issue of premature death. In contrast, YLL provides a more accurate depiction of premature death by weighting deaths occurring at younger ages more heavily than those occurring in older populations, and may therefore function as an additional tool for quantifying the burden of cancer.
To better understand the burden of cancer at the population level, we estimated the burden of cancer in a cohort study using mortality and YLL according to life tables in Japan.
Methods

Study population
Study subjects were the participants of the Miyako Study, a cohort study conducted a general population derived from four areas of Fukuoka Prefecture, Japan. Details of the present cohort have been described elsewhere. [5] [6] [7] Briefly, the baseline survey was conducted from 1986 to 1989. We invited all inhabitants aged 30-79 years living in A town, B village and selected districts of C city and D town (15 417 subjects in total) to participate in a self-administered questionnaire survey. Unweighted sampling was used to combine the participants of these four areas. Response rate was 86.1%, equivalent to 13 270 subjects, who constituted the cohort. The baseline data were collected by means of a self-administered questionnaire that elicited information on sociodemographic characteristics and lifestyle-related factors.
We then followed these 13 270 subjects for vital status to verify whether they had died or relocated. Data were updated annually with the collaboration of the respective municipal office until the end of 1999 in one of the study areas and until the end of 2003 in the other three. For subjects who died, the underlying cause of death during the study period was ascertained from the death certificate and coded according to the International Classification of Diseases and Injuries (ICD), ninth revision (ICD-9).
The research protocol of this study was approved by the Ethics Committee of Medical Care and Research of the University of Occupational and Environmental Health, Kitakyushu, Japan. Informed consent was obtained at the group level after the study objective and confidentiality of the data were explained to community leaders.
Life tables for Japan
In Japan, the Ministry of Health, Labour and Welfare reports complete life tables every 5 years. The tables show functional data by age for death rate, survival rate and remaining life expectancy. These data are aimed at allowing close analysis of mortality, assuming that the deaths in the base year of the life table are constant. In the present analyses, we used the 1995 complete life tables 8 to estimate YLL. According to these life tables, life expectancy at birth was 76.46 years for men and 82.96 years for women.
Statistical analysis
In order to compute mortality rate, the number of personyears of follow-up for each subject was counted from the study baseline until the date of death, date of migration from the study area or end of follow-up, whichever occurred first. Crude mortality rate per 100 000 person-years from deaths due to all cancers as well as site-specific cancers was calculated.
We computed YLL by estimating the difference between the actual age at death of a subject who died from cancer and the expected age at death. We used the following formula to compute YLL X d i ðE À iÞ where i = actual age at death; d i = number of deaths at age i and E = expected age at death estimated according to the 1995 life tables, based on age and gender.
YLL can then be expressed as a percentage (%YLL) for each specific cancer; that is, the YLL from a specific cancer as a percentage of the total number of YLL from all cancers. The average years of life lost (AYLL), which is simply an average derived from dividing total YLL by the actual number of deaths for each cancer site, was also calculated.
All statistical analyses were performed using the Stata version 9.0 software package (Stata Corporation, USA). 9 
Results
A total of 78 935 person-years were counted in 5927 men, and 102 982 person-years in 7343 women, with an average follow-up period of 13.7 years (range = 0.5-17.0 years). More than 70% of participants survived to the end of the follow-up period, and there were $10% relocating. Death due to all causes occurred in 2363 subjects (1339 men and 1024 women). Among them, cancer was the leading cause, accounting for 839 deaths (517 men and 322 women), followed by cardiovascular disease in 675 (349 men and 326 women) and respiratory disease in 314 (189 men and 125 women). Thus, the proportion of cancer deaths to death from all causes was 35.5%. Among the 839 cancer deaths, 208 (24.8%) occurred at age 80 years or older, 303 (36.0%) from age 70 to 79 years, 216 (25.8%) from age 60 to 69 years and 112 (13.4%) before age 60 years.
The number of deaths and respective mortality per 100 000 person-years by specific sites of cancer are shown in table 1. Deaths due to stomach, liver and lung cancer were the three leading causes of cancer death in both sexes. Overall crude cancer mortality was 654.9 per 100 000 person-years in men and 312.6 in women. Table 2 shows YLL, %YLL and AYLL of cancer estimated using the 1995 life tables. Total YLL due to cancer was 7035.3 years in men and 5627.0 years in women. Among men, liver cancer accounted for the greatest part of the cancer burden, with 1693.6 years lost, accounting for 24.1% of total YLL; followed by stomach cancer with 1437.3 years (20.4%); and lung cancer with 1035.1 years (15.0%). Among women, the most costly cancer was cancer of the stomach, which caused With regard to AYLL, the observed cost in overall AYLL was greater for women (17.5 years) than men (13.6 years). In men, cancers of the esophagus, liver and leukemia were the most affected, with AYLL of >16 years, followed by stomach and colorectal cancer with AYLL of about 14 years. In women, cancers of the breast, cervix uteri and ovary were most affected, with AYLL of 28.5, 25.3 and 23.4 years, respectively, while stomach, rectum, liver, lung and thyroid cancer as well as leukemia all had AYLL of >16 years.
Discussion
In this study, mortality from cancers as well as YLL was estimated based on a cohort study in Japan. We found that cancer was the leading cause of death over an average of 13.7 years of follow-up. Numbers of YLL due to cancer were also accounted according to the life tables in Japan.
In addition to mortality, we also estimated cancer burden using the complementary measures of YLL and AYLL. The YLL represents the population burden as a whole, whereas AYLL provides a measure of the effect of a cancer in shortening the patient's life. Both indicators give greater weight to diseases that affect younger patients or whose cure rates are low, and less weight to conditions affecting the elderly. In men, for instance, while esophagus, stomach, colorectal and liver cancer had a closely similar impact, with AYLLs of >14 years for each, prostate cancer had less impact because it generally affects relatively older males, often those over 75 years old and had an AYLL of 9.5 years. In contrast, breast cancer affected younger women, who died an average of 28.5 years earlier than expected in our study, whereas women with cancer at other sites died from 9.5 to 17.6 years before expected. Mass screening programs for breast cancer would therefore likely be effective in reducing mortality in this condition, and save a remarkable numbers of years lost.
10,11
The method for calculating YLL varies among authors, depending on cut-off age or life tables of different populations.
3,4,12-15 Romeder and McWhinnie 15 suggested a cut-off at age 70 years, while Semerl and Sesok 12 used 65 years. Confusion about the use of this measure stems from differing views of the value, which should be applied to age at death, and any comparison of YLL among different studies should take account of the cut-off age or life tables used. Consistent with some previous studies, 4, 14 we estimated YLL using life expectancy at actual age at death as reported in national life tables. Given that life expectancy listed in these tables differs for each specified age, the use of the life tables to compute YLL may be more suitable than a fixed age cutoff.
In Japan, the complete life tables were first published for the period 1891-98. They are now constructed every 5 years based on the national population census and the final report of the annual vital statistics. Although, life expectancy at birth during our present follow-up period from 1987 to 2003 increased in both men (75.61-78.36 years) and women (81.39-85.33 years), 1 we decided to use the 1995 life tables as this represented the mid-point of the follow-up period. The greater overall AYLL in women over men (17.5 and 13.6 years, respectively) may be due in part to the $6-years' gap in life expectancy at birth between men and women. Given this possibility, YLL in the present study was estimated using life tables differentiated by sex. Results should be interpreted carefully, as AYLL may be expected to increase in accordance with longer life expectancy in women.
Mortality, YLL and AYLL are all representative measures of the burden from cancer. Mortality rates show the risk for a person dying from cancer while YLL or AYLL reflect by how many years earlier than the expected age the person died. In the present study, these indicators consistently indicated that the greatest burden lay with stomach, liver and lung cancer in both sexes, but AYLL revealed that the largest average shortening occurred with sex-related cancers in women, such as breast, cervix uteri and ovarian cancer. Age at death may be considered a measure of cancer burden. We all expect to die at an older rather than younger age. The complementary indicators used here may show different aspects of cancer mortality, or may identify other impacts. Both YLL and AYLL due to cancer may be expected to decrease in accordance with an increased cure rate for specific cancer sites. Other social Years of life lost due to cancer aspects, such as quality of life, may also be considered. Many of these deaths may be postponed or avoided if appropriate interventions are adopted, such as primary prevention, mass screening or improvement of treatment effectiveness. Several limitations to the present study warrant mention. First, sampling was conducted on 13 270 participants in four study areas in Fukuoka prefecture, and thus we cannot guarantee that our cohort study was representative of Japan as a whole. Second, we showed crude mortality rather than age-adjusted mortality, given the age ranges of study participants were 30-79 years old at baseline. And any comparison of our data with those of other countries should therefore be conducted with caution.
In summary, these results showed that cancer was the leading cause of death in a cohort study in Japan; with stomach, liver and lung cancer the three most frequent cancers in both sexes. YLL and AYLL reflect the cost of dying from cancer in terms of years of life expectancy lost. The different mortality statistics used here may be useful in public health considerations of cancer burden.
